Main navigation

• Home
• About us
• Medicines
• Research
• Careers
• Responsibility
• Partnering
• Media
• Investors
  • Directors' shareholdings
  • Financial calendar
  • Annual reports
  • Financial highlights
  • Strategy
  • Investor contacts
  • Corporate governance
  • Shareholder information
  • Investor tools
  • SEC filings
  • Financial results
  • Presentations & webcasts
  • FAQs
    • Dividends
    • Registered shareholders
    • Mergers / demergers

You are here

• Home
• Investors

• FAQs

• • When was AstraZeneca PLC formed?
  • Where can I find historical financial information on AstraZeneca?
  • How much does AstraZeneca invest in research and development (R&D)?
  • How many people does AstraZeneca employ worldwide?
  • When is the AstraZeneca annual meeting?
  • When is AstraZeneca’s next earnings release?
  • On what stock exchanges is AstraZeneca traded and what is the stock symbol?
  • What is AstraZeneca's current debt rating?
  • What is AstraZeneca's CUSIP number for its ADRs/ADSs traded on the New York Stock Exchange?
  • How many shares does AstraZeneca have outstanding?
  • What accounting convention does AstraZeneca adhere to?
  • What is AstraZeneca's official accounting currency?

• • When was AstraZeneca PLC formed?

    AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca PLC of UK.

    Back to top

  • Where can I find historical financial information on AstraZeneca?

    This information can be found in the financial results section.

    Back to top

  • How much does AstraZeneca invest in research and development (R&D)?

    In 2008 we invested $5.2 billion on R&D.

    Back to top

  • How many people does AstraZeneca employ worldwide?

    We employ over 65,000 people worldwide.

    • 51% in Europe
    • 32% in the Americas
    • 17% in Asia, Africa and Australasia

    Back to top

  • When is the AstraZeneca annual meeting?

    The 2010 Annual General Meeting will be held on Thursday, 29 April 2010 in London.

    Back to top

  • When is AstraZeneca’s next earnings release?

    Third quarter and nine months results 2009 were announced Thursday 29 October. View details of the event.

     

    Fourth quarter and full year results 2009 will be announced on Thursday 28 January 2010.

     

    Back to top

  • On what stock exchanges is AstraZeneca traded and what is the stock symbol?

    AstraZeneca is traded on the London, New York and Stockholm Stock Exchanges. The symbol is AZN in all three markets. View interactive charts for the London, New York and Stockholm stock exchanges.

    Back to top

  • What is AstraZeneca's current debt rating?

    Moody's :
    Long term: A1, Short term: P-1, Outlook: Stable
    Standard & Poor's :
    Long term AA-, Short term A-1+, Outlook: Stable
    Fitch :
    Long term AA-, Short term F1+, Outlook: Stable

    Back to top

  • What is AstraZeneca's CUSIP number for its ADRs/ADSs traded on the New York Stock Exchange?

    046353108

    Back to top

  • How many shares does AstraZeneca have outstanding?

    As at 30 September 2009 there were 1,450 million shares in issue.

    Back to top

  • What accounting convention does AstraZeneca adhere to?

    AstraZeneca adheres to the International Financial Reporting Standards (IFRS) and International Accounting Standards (IAS) with appropriate conversion to US GAAP being shown in our financial statements.

    Back to top

  • What is AstraZeneca's official accounting currency?

    AstraZeneca reports in US dollars.
    

    Back to top

Not signed in

Page tools

• Print
• Bookmark this page

Share price